www.medical-research-study-directory.info A very important question to ask your prostate cancer surgeon before your prostatectomy! prostate cancer, cancer, prostate cancer surgery, prostate cancer pathology,Prostate Cancer Surgery Pathology, Prostate Cancer Pathology http Video Rating: 5 / 5
“Final Treatment.” To all those men who’ve just been diagnosed with prostate cancer: your world is not over. With his 28 days of radiation completed, Rick says a poignant goodbye to his OHSU Knight Cancer Institute prostate cancer treatment team. Relieved and happy that the prostate cancer treatment is finished, he considers his future as a cancer survivor. www.ohsuhealth.com/prostatecancer Video Rating: 0 / 5
Dr. Chad LaGrange explains the benefits of minimally invasive robotic surgery to treat prostate cancer. To learn more, call 1-800-922-0000 or visit www.nebraskamed.com. Video Rating: 0 / 5
Question by shonester: Which candidate successfully got increased funding for prostate cancer and childhood asthma? Clinton or Obama? Increased research funding for prostate cancer and childhood asthma at the National Institutes of Health? I looked it up and it was Hillary. You are right.
Question by sunshine: does anyone know about prostate cancer treatment in Canada? My soon-to-be father-in-law has been diagnosed with prostate cancer and was told that they have new technology for treatment in Canada, where they use laproscopy (i think this is what he is describing). Does anyone know anything about this? Why is it not done here in the states? What is the recovery process and how sucessful is it really?
Best answer:
Answer by Carl M I live in Canada and my dad had prostate cancer about 11 years ago. They caught it early enough and he went with radiation treatment. I believe laparoscopic surgery involves removing the prostate which some men choose. My dad had radiation treatment, where the prostate isn’t actually removed but the cancer is hit with radiation. You might want to keep checking because I believe laparoscopic treatment is widely available in the US too.
Things turned out fine for my dad fortunately and I hope your father in law’s prognosis is positive too.
Question by Lebesgue: Should I expect an advanced state of prostate cancer if the PSA level is of 45? The father of a friend of mine has just been diagnosed with prostate cancer, his PSA is of 45, but till now there haven’t been any noticeable symptoms, and we were wondering how advanced the cancer would be…
Best answer:
Answer by Stephen Its likely to have spread but its treatable
There are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer.
Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy – an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) – surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery – this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence.
Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.
Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy
The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy’s side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped.
Antioxidant Levels Are Key To Prostate Cancer Risk In Men
Greater levels of selenium, vitamin E and the tomato carotenoid lycopene have been shown to reduce prostate cancer in one out of every four Caucasian males, or those who inherit a specific genetic variation that is particularly sensitive to oxidative stress, say US researchers.
Conversely, if carriers of this genetic variant have low levels of these vitamins and minerals, their risk of aggressive prostate increases substantially, as great as 10-fold, over those who maintain higher levels of these nutrients, they write in today’s issue of Cancer Research.
“This large prospective study provides further evidence that oxidative stress may be one of the important mechanisms for prostate cancer development and progression, and adequate intake of antioxidants, such as selenium, lycopene and vitamin E, may help prevent prostate cancer,” said Dr Haojie Li, a researcher at the Brigham and Women’s Hospital and Harvard Medical School.
The new findings are based on an analysis of 567 men diagnosed with prostate cancer between 1982 and 1995, and 764 cancer-free men from the Physicians Health Study.
The initial goal of this study was to assess the effect of aspirin and beta-carotene on men’s health. Li’s team decided to check for variants of the gene that codes for manganese superoxide dismutatase (MnSOD), an important enzyme that works as an antioxidant in human cells to defend against disease.
The MnSOD gene is passed from parents to offspring in one of three forms: VV, VA or AA.
“Compared with men with the MnSOD VV or VA genotype, people with the AA genotype seem to be more sensitive to the antioxidant status,” said Li. “Men with the AA genotype are more susceptible to prostate cancer if their antioxidant levels are low.”
The study’s results found that a quarter of the men in the study carried the MnSOD AA genotype, half carried the VA genotype, and the remaining quarter carried the VV genotype.
The results indicated that the VA and VV men were at equivalent risk for developing prostate cancer across all levels of antioxidants in their blood.
But compared to MnSOD VV or VA carriers in the lowest quartile of selenium levels, MnSOD AA males had an 89 per cent greater risk for developing aggressive prostate cancer if they had low blood levels of the mineral.
On the other hand, MnSOD AA carriers with high selenium – those men in the highest quartile – had a 65 per cent lower risk than the MnSOD VV or VA males who maintained low levels of selenium.
“The levels of selenium in the highest quartile of these men are not abnormally high,” Li said. “Our range is neither extremely high nor extremely low.”
While similar trends were observed for lycopene and vitamin E when tested independently, the contrast in relative risk was most pronounced for the men who had high blood levels for all three antioxidants combined, said the researchers.
“Among men with the MnSOD AA genotype, we observed a 10-fold difference in risk for aggressive prostate cancer, when comparing men with high versus low levels of antioxidants combined,”said Li. “In contrast, among men with the VV or VA genotype, the prostate cancer risk was only weakly altered by these antioxidant levels.”
“Our study, as well as many other epidemiological studies, encourages dietary intake of nutrients such as lycopene from tomato products, or supplements for vitamin E and selenium to reduce risk of prostate cancer,” said Li.
Prostate cancer is one of the biggest cancer killers in industrial countries and affects more than 500,000 men worldwide every year. This number is expected to increase with the ageing population.
Similar interactions between dietary antioxidants and the variations in the MnSOD gene have previously been linked to risk for breast cancer.
For more information visit: The Official Protacet Website
www.vci.org Alternative Treatment for Prostate Cancer Hyperthermia is the most successful and low side effects cancer tratment available in the world. Dr James Bicher, a pioneer in the field of Hyperthermia, has been successfully treating pations for over 30 years with this FDA approved cancer treatment modality. Hyperthermia does not have the sexual side effects of impotence, incontinence, and possible diarrhea. Those sexual side effects from surgery, high radiation does, hormone therapy, or chemotherapy, could be temporal (moths or up to two years) or permanent. # Alternative Approaches to Prostate Cancer – Michael Schachter MD … All prostate cancer patients should use alternative cancer therapies. In general, they should be used prior to beginning conventional treatment. … www.healthy.net (Alternative Prostate Cancer) treatment Holistic( Prostate Cancer … (Alternative Prostate Cancer) treatment Holistic Prostate Cancer cure, VCI researches and clinically uses Hyperthermia, natural less toxic cancerocidal … www.vci.org treatments for prostate cancer, prostate cancer treatment … Prostate Cancer Treatment | Alternative Prostate Cancer Treatment |. institute for cancer research. APJohn. Prostate Cancer … www.apjohncancerinstitute.org – Alternative prostate cancer treatment alternative prostate cancer treatment – Prostate cancer is an attack of the male prostate gland by a mass of harmful cells. Prostate cancer is most common. www.dart-creations.com Video Rating: 5 / 5
Women Against Prostate Cancer’s Betty Gallo To Testify At House Prostate Cancer Hearing
Women Against Prostate Cancer announces its co-founder, Betty Gallo, will testify at the House Committee on Oversight and Government Reform hearing “Prostate Cancer: New Questions About Screening and Treatment.” Gallo’s late husband, former Congressman Dean Gallo, battled prostate cancer and her testimony will represent the millions of wives, partners, sisters, mothers and daughters impacted by this disease. In addition to Ms. Gallo’s testimony, WAPC will submit written testimony to bring clarity to hearing’s discussion on key issues, including advocating for:
• Increased support, education for partners, caregivers and family after a prostate cancer diagnosis
• Early detection and appropriate treatment of clinically significant and potentially lethal prostate cancer, especially among men at high risk because of family history, ethnicity or other factors
• Coverage by health care insurance plans for the two annual prostate cancer tests, prostate-specific antigen (PSA) and digital rectal examination (DRE), as well as follow-up diagnostic testing when appropriate
]]>
• Additional funding for research into more effective ways to identify and discriminate between low risk (“indolent”) and higher risk (“clinically significant and potentially lethal”) forms of prostate cancer, as well as management for patients with or at risk for potentially lethal prostate cancer
Additionally, Theresa Morrow, Co-Founder of Women Against Prostate Cancer, stresses the importance of this House hearing as a way to increase prostate cancer awareness:
“Prostate cancer is a complex and problematic disease that affects not only the male patient but can also be devastating to his wife or partner and other family members. Approximately 2 million men currently live with prostate cancer and there are countless partners, spouses and loved ones who are also suffering from the effects of this disease. There has been a reported increase in the percentage of younger men (35 – 60 years old) being diagnosed with metastatic prostate cancer, which can cause additional strain and stress placed on families with young children, who may face the possibility of growing up without a father.
“Over the past year, a number of prostate cancer studies have prompted a significant debate on important prostate cancer issues, such as screening, diagnostic testing, diagnosis, treatment, comparative effectiveness of treatments. The controversy around these issues has created confusion for the public. Men are often unsure if and when they should be screened for prostate cancer and some doctors aren’t sure if they should be performing prostate screenings.
“WAPC encourages physicians and their adult male patients discuss personal risks for prostate cancer and the individual need for prostate cancer testing at each patient’s annual physical exam. Also, men at higher levels of risk for prostate cancer due to ethnicity, family history, and other factors should be encouraged to undergo appropriate tests at a relatively early age.”
A live webcast of the House Hearing on prostate cancer is available at: http://oversight.house.gov/index.php?option=com_jcalpro&Itemid=2&extmode=view&extid=126
Women Against Prostate Cancer (WAPC) is a national organization that provides support for the millions of women, and their families, who are affected by prostate cancer. WAPC promotes prostate cancer awareness through education, legislation and prostate cancer support groups.
Hormone therapy used to be the last line of defense against metastatic prostate cancer, but doctors are increasingly using it earlier in treatment because of its benefits when added to radiation therapy. However, blocking the production of testosterone is not the best approach for every patient. Michael Morris, MD, of Memorial Sloan-Kettering Cancer Center discusses the potential side effects of hormone therapy, and the potential benefits and risks for individual patients. For more information, please visit www.mskcc.org Video Rating: 0 / 5
Question by Jason: Why didn’t anyone talk about prostate cancer awareness last month? This month is breast cancer awareness and you see ads everywhere for that, what about prostate cancer??
Does anyone only care about females and their breasts?? I don’t thats for sure.
Best answer:
Answer by Fireball good point…they are all important!!!
Question by Tara Impact: What is the laser treatment for prostate cancer? I was wondering if anyone knew how the green light laser prostate cancer treatment worked. i found http://www.birminghamprostateclinic.co.uk/greenLightLaser.php which has some good information but I need a bit more detail.
Best answer:
Answer by Borovich Laser is used to cut out the cancer without damaging the nerves. Need a doctor skilled in it.